Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma
Open Access
- 15 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 28 (31), 2821-2828
- https://doi.org/10.1038/onc.2009.137
Abstract
Deletion of 3p is one of the most frequent genetic alterations in many tumors, including esophageal squamous cell carcinoma (ESCC). In our recent study, deletion of 3p24 was frequently detected in ESCC and one candidate tumor suppressor gene (TSG), p300/CBP-associated factor (PCAF), was identified within the region. In this study, downregulation of PCAF was detected in 23/40 (57.5%) of primary ESCCs and 4/9 (44.4%) of the ESCC cell lines. A further study found that downregulation of PCAF was also associated with hypermethylation of the promoter region of PCAF gene. Methylation-specific PCR found that promoter methylation was detected in 28/40 (70%) of primary ESCCs and 5/9 (55.6%) of ESCC cell lines. In addition, the expression of PCAF could be reactivated in ESCC cell line KYSE510 after demethylation treatment with 5-aza-dC. Functional studies showed that PCAF was able to suppress tumorigenicity of ESCC cells both in vitro and in vivo, including foci formation, colony formation in soft agar and tumor formation in nude mice. Molecular study found that the tumor suppressive mechanism of PCAF was associated with its role in cell cycle arrest at the G1/S checkpoint by the downregulation of CDK2 and upregulation of p21waf1/Cip1, Smad4, Rb and p27Kip1. In conclusion, PCAF might be the target TSG responsible for the 3p24 deletion event, which has an important role in the development and progression of ESCC.Keywords
This publication has 27 references indexed in Scilit:
- Characterization of a Novel Tumor-Suppressor Gene PLCδ1 at 3p22 in Esophageal Squamous Cell CarcinomaCancer Research, 2007
- p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinomaJournal of Clinical Pathology, 2007
- p300 plays a role in p16INK4a expression and cell cycle arrestOncogene, 2007
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- PCAF is a coactivator for p73-mediated transactivationOncogene, 2003
- Heterogeneous expression and association of β‐catenin, p16 and c‐myc in multistage colorectal tumorigenesis and progression detected by tissue microarrayInternational Journal of Cancer, 2003
- Ätiologie, Molekularbiologie und Pathologie des Plattenepithelkarzinoms des ÖsophagusDer Pathologe, 2000
- Tumor Suppressor Gene Smad4/DPC4, Its Downstream Target Genes, and Regulation of Cell CycleaAnnals of the New York Academy of Sciences, 1999
- A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1ANature, 1996
- Characterization of 21 newly established esophageal cancer cell linesCancer, 1992